HomeCompareSMDPY vs FCPT

SMDPY vs FCPT: Dividend Comparison 2026

SMDPY yields 16.48% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FCPT wins by $26.4K in total portfolio value· pulled ahead in Year 2
10 years
SMDPY
SMDPY
● Live price
16.48%
Share price
$12.14
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.6K
Annual income
$1.85
Full SMDPY calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — SMDPY vs FCPT

📍 FCPT pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMDPYFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMDPY + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMDPY pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMDPY
Annual income on $10K today (after 15% tax)
$1,400.91/yr
After 10yr DRIP, annual income (after tax)
$1.57/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, FCPT beats the other by $4,907.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMDPY + FCPT for your $10,000?

SMDPY: 50%FCPT: 50%
100% FCPT50/50100% SMDPY
Portfolio after 10yr
$35.9K
Annual income
$2,888.57/yr
Blended yield
8.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

SMDPY
No analyst data
Altman Z
2.3
Piotroski
6/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMDPY buys
0
FCPT buys
0
No recent congressional trades found for SMDPY or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMDPYFCPT
Forward yield16.48%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%15.8%
Portfolio after 10y$22.6K$49.1K
Annual income after 10y$1.85$5,775.28
Total dividends collected$1.7K$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: SMDPY vs FCPT ($10,000, DRIP)

YearSMDPY PortfolioSMDPY Income/yrFCPT PortfolioFCPT Income/yrGap
1$11,524$824.06$11,401$700.92+$123.00SMDPY
2← crossover$12,775$443.76$13,064$864.84$289.00FCPT
3$13,899$229.87$15,051$1,072.48$1.2KFCPT
4$14,988$116.87$17,442$1,337.22$2.5KFCPT
5$16,096$58.89$20,340$1,677.08$4.2KFCPT
6$17,253$29.55$23,880$2,116.57$6.6KFCPT
7$18,475$14.80$28,241$2,689.36$9.8KFCPT
8$19,776$7.41$33,660$3,442.07$13.9KFCPT
9$21,164$3.70$40,456$4,439.95$19.3KFCPT
10$22,647$1.85$49,063$5,775.28$26.4KFCPT

SMDPY vs FCPT: Complete Analysis 2026

SMDPYStock

Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides products for atypical antipsychotic, cultured thymus tissue for pediatric congenital athymia, antiepileptic, and carbapenem antibiotic; and Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, as well as seasonings, such as soups or bouillons; and chemical product materials, which include pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, such as dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application; Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio Company Limited; and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company also has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

Full SMDPY Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this SMDPY vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMDPY vs SCHDSMDPY vs JEPISMDPY vs OSMDPY vs KOSMDPY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.